Transistor (https://transistor.fm) https://feeds.transistor.fm/show-title Welcome to Research Pod © 2025 Eclipse Clinical Trial ceb3eb47-adf2-526b-bb8e-b61ef89a7b64 no en Wed, 23 Jul 2025 15:35:11 +0100 Wed, 03 Dec 2025 01:48:19 +0000 https://eclipseclinicaltrial.org/ https://img.transistor.fm/OK53KyQOjIljIpRNbfwALQ7vkoZYH_sroLrGcW34PVw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNzA0LzE2ODE0/MTUwMjUtYXJ0d29y/ay5qcGc.jpg https://eclipseclinicaltrial.org/ episodic Eclipse Clinical Trial Welcome to Research Pod Welcome to Research Pod. Curium Pharma No No 1 1 Shedding a light on ECLIPSE full 225dc671-c5db-42b3-b9df-0bd94991b6a6 https://share.transistor.fm/s/b8b654f9 In this 15-minute podcast, Sakir Mutevelic, MD, MSc, Curium’s chief medical officer, discusses the ECLIPSE trial in greater detail, including eligibility criteria and how to enroll patients. In addition, he describes the role of radiopharmaceuticals in diagnosing and treating prostate cancer and a patient’s typical diagnostic journey. 

]]> In this 15-minute podcast, Sakir Mutevelic, MD, MSc, Curium’s chief medical officer, discusses the ECLIPSE trial in greater detail, including eligibility criteria and how to enroll patients. In addition, he describes the role of radiopharmaceuticals in diagnosing and treating prostate cancer and a patient’s typical diagnostic journey. 

]]> Thu, 13 Apr 2023 20:35:52 +0100 Eclipse Clinical Trial Eclipse Clinical Trial 966 In this 15-minute podcast, Sakir Mutevelic, MD, MSc, Curium’s chief medical officer, discusses the ECLIPSE trial in greater detail, including eligibility criteria and how to enroll patients. In addition, he describes the role of radiopharmaceuticals in diagnosing and treating prostate cancer and a patient’s typical diagnostic journey. 

]]> No